MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$47,594,000
Accretion of discount on
investments, net
$1,229,000
Interest and other
income, net
$161,000
Loss from operations
-$48,511,000
Interest expense
$473,000
Total operating
expenses
$48,511,000
Research and development
$31,454,000
General and
administrative
$17,057,000
Back
Back
Income Statement
source: myfinsight.com
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)